Orthopedics, Arthroplasty and Rheumatology

Targeted Therapies for Rheumatic Diseases

Targeted Therapies for Rheumatic Diseases focuses on the latest advances in treatments that specifically target the underlying mechanisms of conditions like rheumatoid arthritis and lupus. Biologic agents, such as TNF inhibitors and IL-6 blockers, are revolutionizing care by selectively targeting inflammatory pathways, leading to more effective symptom control and reduced joint damage. JAK inhibitors are also emerging as an oral treatment option, offering flexibility for patients who may not respond to biologics. These targeted therapies are personalized to individual genetic profiles, ensuring a more precise and tailored approach to treatment. In addition, regenerative treatments like stem cell therapy are being explored to repair damaged tissues and improve long-term outcomes. These therapies are transforming the management of rheumatic diseases, providing better control of inflammation, minimizing side effects, and improving patients' quality of life.